lamp reaction mixtures (New England Biolabs)
Structured Review

Lamp Reaction Mixtures, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 99 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lamp+primer+mixture/Control+LAMP+Primer+Mix/med_rxiv__2025__07__25__25332228-276-2-36
Average 95 stars, based on 99 article reviews
Images
1) Product Images from "International Multi-site Implementation of Local Cell-Free Protein Biomanufacturing to Advance Health and Research Equity"
Article Title: International Multi-site Implementation of Local Cell-Free Protein Biomanufacturing to Advance Health and Research Equity
Journal: medRxiv
doi: 10.1101/2025.07.25.25332228
Figure Legend Snippet: (a) Schematic representation of the pipeline used to create the molecular diagnostic systems. Detection was carried out using real-time fluorescence or visual detection. For fluorescence measurements, amplicons were visualized by adding 1x LAMP fluorescent dye or 10 μM SYTO 9 Green Fluorescent Nucleic Acid dye if FluoroPLUM was used, with fluorescence reads every minute. For visual detection, the naked eye confirmed amplification under natural light by adding SYBR Gold Nucleic Acid Stain (diluted 1:10) to tube caps before reaction incubation, followed by mixing after incubation. A positive reaction resulted in a color change from orange to yellow, while a negative reaction remained orange. (b) End point fluorescence levels (25 minutes for all targets) for 16 pathogens, comparing in-house (blue) and commercial LAMP systems (green). Data are shown as mean ± SD, n = 3. (c) Real-time fluorescent experiments for synthetic P. falciparum DNA amplification using a conventional qPCR instrument. This representative data was obtained using reagents produced on-site in Canada. Data are shown as mean ± SD, n = 3. (d) Real-time fluorescent experiments for synthetic SARS-CoV-2 RNA amplification using a conventional qPCR instrument. This representative data was obtained using reagents produced on-site in Canada. Data are shown as mean ± SD, n = 3. (e) Reproducibility assessment of LAMP and RT-LAMP performed in Canada, Chile, Brazil, and Colombia. Independent experiments conducted by different teams across diverse settings, using a standardized protocol, confirmed the reproducibility of the results. The consistent results reinforce the feasibility of decentralized enzyme production. (f) Comparison of the low-cost, portable FluoroPLUM and a conventional high-cost qPCR machine for assessing in-house-produced LAMP reactions, with results showing comparable performance across both platforms, confirming the utility of FluoroPLUM as an affordable alternative for high-throughput measurements in low-resource settings. (g) Real-time fluorescence and visual outputs of LAMP reactions using P. falciparum synthetic DNA (2 nM) and NTC measured with the low-cost, portable FluoroPLUM. This representative data was obtained using reagents produced on-site in Canada. Data are shown as mean ± SD, n = 3. (h) Real-time fluorescence and visual outputs of LAMP reactions using L. braziliensis synthetic DNA (2 nM) and NTC measured with the low- cost, portable FluoroPLUM. This representative data was obtained using reagents produced on-site in Canada. Data are shown as mean ± SD, n = 3. (i) Deploying low-cost cell-free lysates and open-source hardware enables decentralized biomanufacturing, facilitating the implementation of diagnostic programs in resource-limited settings. (j) End point fluorescence levels (30 minutes for all targets) for B. burgdorferi , POWV, and M. tuberculosis measured using the low-cost, portable FluoroPLUM. This representative data was obtained using diagnostic reagents manufactured on-site in Algonquin Highlands, Ontario, Canada. Data are shown as mean ± SD, n = 3. Abbreviations are: (-) or NTC, non-template control; RT, room temperature; Min, minutes; HIV-1, human immunodeficiency virus 1; CHIKV, chikungunya virus; MPXV, monkeypox virus; ZIKV, Zika virus; DENV-2, dengue virus serotype 2; WNV, West Nile virus; MAYV, Mayaro virus; POWV, Powassan virus; OROV, Oropouche virus.
Techniques Used: Diagnostic Assay, Fluorescence, Amplification, Staining, Incubation, DNA Amplification, Produced, RNA Amplification, Comparison, High Throughput Screening Assay, Control, Virus
Figure Legend Snippet: (a) Countries where diagnostics were manufactured on-site and successfully used to establish disease diagnostic programs. Colors correspond to the data shown in subsequent panels, representing the countries where the data was collected. (b) The functionality of on-site-produced RT-LAMP reactions was further tested with RNA isolated from cultured SARS-CoV-2 virus. Fluorescence measurements after 20 minutes of incubation were plotted. Data are shown as mean ± SD, n = 3. (c) Patient trials for a locally produced SARS-CoV-2 diagnostic program were conducted in four different countries: Brazil, Colombia, Chile, and Canada. RNA samples isolated from patients were analyzed via RT-LAMP, where fluorescence increases indicate successful amplification. Fluorescence after 20 minutes (y-axis) was plotted against corresponding Ct values obtained via CDC RT-qPCR gold-standard assays (x-axis). In-house diagnostic tests demonstrated diagnostic accuracy ranging from 90% to 100%. The dashed line represents the threshold value defined for RT-qPCR analysis. See Supplementary Information for detailed analysis. (d) The functionality of on-site-produced RT-LAMP reactions was further tested with RNA isolated from cultured chikungunya virus. Fluorescence measurements after 30 minutes of incubation were plotted. Data are shown as mean ± SD, n = 3. (e) Patient trial for chikungunya virus was conducted in Brazil using locally produced, on-demand diagnostics. RNA samples isolated from patient samples were analyzed via RT- LAMP using 10 μM SYTO 9 Green fluorescent nucleic acid dye, where fluorescence increases indicated successful amplification. Fluorescence after 30 minutes (y-axis) was plotted against the corresponding Ct values obtained using the CDC RT-qPCR gold-standard assays (x-axis) in parallel. The dashed line represents the threshold value defined for RT-qPCR analysis . (f) Cultured Oropouche virus was processed using three methods: (1) commercial column extraction, (2) simple boiling at 95 °C for 2 minutes, and (3) direct use of the cultured virus without pretreatment. Each sample was tested using on-site-produced RT- LAMP reactions with LAMP fluorescent dye to detect the virus, with all three methods yielding successful detection. Data are shown as mean ± SD, n = 3. (g) Patient trial for Oropouche virus was conducted in Brazil using locally produced, on-demand diagnostics. RNA samples isolated from patient samples were analyzed via RT-LAMP using 1X LAMP fluorescent dye, where fluorescence increases indicated successful amplification. Fluorescence after 40 minutes (y-axis) was plotted against the corresponding Ct values obtained using the RT-qPCR gold-standard assays (x-axis). The dashed line represents the threshold value defined for RT-qPCR analysis. (h) In parallel with the CDC RT-qPCR gold standard, in-house diagnostic tests for SARS-CoV-2, chikungunya, and Oropouche viruses demonstrated accuracy ranging from 90% to 100%. During this project phase, RNA quality and integrity were verified in all patient samples using the human endogenous controls for Ribonuclease P (RT-qPCR) and Beta-actin (RT-LAMP). See Supplementary Information for detailed analysis (Tables S6-12). Abbreviations are: NTC, non-template control; CHIKV, chikungunya virus; OROV, Oropouche virus; Ct, cycle threshold.
Techniques Used: Diagnostic Assay, Produced, Isolation, Cell Culture, Virus, Fluorescence, Incubation, Amplification, Quantitative RT-PCR, Extraction, Control


